Table 1.
Demographic and clinical characteristics of the study cohort.
| Variables | Sample, n = 899 |
|---|---|
| Age (years) | |
| Mean ± SD | 70.3 ± 9.8 |
| Range | 40–90 |
| Gender, number (%) | |
| Male | 364 (40.5) |
| Female | 535 (59.5) |
| UDVA (LogMAR), mean ± SD | |
| Better eye | 0.48 ± 0.31 |
| Worse eye | 0.76 ± 0.37 |
| LOCS III score, mean ± SD | |
| NO | 2.77 ± 0.80 |
| C | 2.45 ± 0.98 |
| P | 2.22 ± 1.20 |
| Systemic comorbidity, number (%) | |
| Hypertension | 385 (42.8) |
| Diabetes | 205 (22.8) |
| Heart disease | 110 (12.2) |
| Cerebrovascular disease | 35 (3.9) |
C = cortical, LOCS III = Lens Opacities Classification System III, NO = nuclear opalescence, P = posterior subcapsular, SD = standard deviation, UDVA = uncorrected distance visual acuity.